I thought I would ask chatGPT:
“do a short summary of this article listing the people and their discoveries”
The article is Business Insider’s 2026 list of 11 “Rising Stars of Longevity” — people working on aging biology, longevity medicine, AI drug discovery, policy, clinical standards, and investment. The list was chosen for evidence-based work and innovation in longevity. (Business Insider)
| Person | Main discovery / contribution |
|---|---|
| Daniel Belsky | Helped establish the idea that people age at different rates, not just different “biological ages”; developed work on pace-of-aging clocks. (Business Insider) |
| Dr. Evelyne Bischof | Promotes healthy longevity medicine using evidence-based testing and personalised prevention; president of the Healthy Longevity Medicine Society. (Business Insider) |
| Peter Fedichev | Uses physics and AI via Gero to identify anti-aging drug targets, including work on fibrosis and age-related disease. (Business Insider) |
| Celine Halioua | Founded Loyal, developing lifespan-extension drugs for dogs; LOY-002 is in Phase 3 trials and may become one of the first approved anti-aging drugs. (Business Insider) |
| Jamie Justice | Leads XPRIZE Healthspan, a major competition funding therapies intended to restore cognition, immunity, and muscle function in aging. (Business Insider) |
| Nathan LeBrasseur | Translates senescent-cell and exercise research into clinical interventions; showed exercise can reduce harmful aging markers in mice and later humans. (Business Insider) |
| Morgan Levine | Developed PhenoAge, a blood-test-based biological aging measure; now builds AI “world models” at Altos Labs to simulate aging interventions. (Business Insider) |
| Dylan Livingston | Founded A4LI, lobbying for policies to improve access to longevity treatments and supporting longevity-related legislation. (Business Insider) |
| Dr. Nicole Sirotin | Developed the world’s first licensed healthy longevity medicine clinic standards in Abu Dhabi, emphasizing evidence-based prevention. (Business Insider) |
| Alex Zhavoronkov | Founded Insilico Medicine, using generative AI for drug discovery; the company reports 28 AI-developed drugs, 12 reaching clinical trials. (Business Insider) |
| Garri Zmudze | Longevity biotech investor; co-founded LongeVC and AniVC, backing evidence-based longevity and animal-health ventures. (Business Insider) |
Overall, the article presents longevity as shifting from fringe “anti-aging” claims toward a more formal field combining biomarkers, prevention, AI drug discovery, exercise biology, veterinary lifespan trials, and health-policy reform.